Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

William A. Freed-Pastor

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7377-2111; OpenAlex author ID A5084073834; NIH RePORTER profile ID 9563534. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
1
Collaborators
49
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 3 papers · 2023: 1 grant · 2024: none · 2025: 1 paper · 2026: 1 paper, 1 grant

Papers 7

  1. Pancreatic cancer-associated organ dysfunction promotes muscle autophagy and contributes to peripheral tissue wasting Co-author DOI 10.64898/2026.02.27.708635↗
  2. Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition. Last author DOI 10.1126/science.adk3487↗
  3. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Co-author DOI 10.1038/s41588-022-01134-8↗
  4. Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-22-1125↗
  5. Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.3390/cancers14246223↗
  6. The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer. Co-author DOI 10.1016/j.ccell.2021.07.007↗
  7. Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment Co-author DOI 10.1101/2020.08.25.267336↗

Grants 2

  1. Elucidating the molecular and cellular mechanisms of immune evasion in pancreatic cancer K08CA259621↗
  2. Career Development Award: William Freed-Pastor (immunopeptidomics for pancreas cancer immunotherapy) AWARD pancan:2023-william-freed-pastor-md-phd-career-development-award-william-freed-p

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brian Matthew Wolpin · 4 shared papers, 2022–2026 · strength 0.64
  2. Tyler Jacks · 4 shared papers, 2020–2026 · strength 0.56
  3. Andrew J. Aguirre · 4 shared papers, 2020–2025 · strength 0.49
  4. James M. Cleary · 3 shared papers, 2022–2025 · strength 0.42
  5. Jonathan Andrew Nowak · 2 shared papers, 2022–2026 · strength 0.32
  6. Zackery A. Ely · 2 shared papers, 2021–2025 · strength 0.27
  7. Harshabad Singh · 2 shared papers, 2022 · strength 0.25
  8. Douglas Adam Rubinson · 2 shared papers, 2022 · strength 0.25
  9. Kimberly J. Perez · 2 shared papers, 2022 · strength 0.25
  10. Yetiş Gültekin · 1 shared paper, 2026 · strength 0.22
  11. Matthew G. Vander Heiden · 1 shared paper, 2026 · strength 0.22
  12. Steven A. Carr · 1 shared paper, 2025 · strength 0.17
  13. Srivatsan Raghavan · 1 shared paper, 2025 · strength 0.17
  14. Philip D. Greenberg · 1 shared paper, 2025 · strength 0.17
  15. William L. Hwang · 2 shared papers, 2020–2021 · strength 0.16
  16. Aviv Regev · 2 shared papers, 2020–2021 · strength 0.16
  17. Rishi Surana · 1 shared paper, 2022 · strength 0.14
  18. Brandon M. Huffman · 1 shared paper, 2022 · strength 0.14
  19. David C. Linehan · 1 shared paper, 2022 · strength 0.10
  20. Albert C. Koong · 1 shared paper, 2022 · strength 0.10
  21. Chen Yuan · 1 shared paper, 2022 · strength 0.10
  22. Richard Francis Dunne · 1 shared paper, 2022 · strength 0.10
  23. Thomas E. Clancy · 1 shared paper, 2022 · strength 0.10
  24. Vicente Morales‐Oyarvide · 1 shared paper, 2022 · strength 0.10
  25. Jiping Wang · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.